investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer
Fraser Symmans
1 Collaborator(s)
Funding source
University of Texas MD Anderson Cancer Center
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Katarzyna Slowinska
Rigid-rod Peptides as Nanocarriers for Delivery of Cancer Drugs
Breast
Jing Yang
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
Breast
Andrea Hope Bild
Integrative signaling models to decipher complex cancer phenotypes
Breast
Dezheng Huo
Epidemiological Study of Breast Cancer in Uganda and Cameroon
Breast
Peter Sicinski
Cyclin-Dependent Kinases in Oncogenesis
Breast
Dimitar B Nikolov
Function-blocking anti-ADAM protease antibodies for inhibition of tumorigenesis - NY
Breast
Christopher Benz
Mass Spectrometry to Decode PTM Patterns and Enhance the Biomarker Utility of ER
Breast
Thomas Spies
Stimulation of Tumorigenesis by NKG2D
Breast
Pathology
Brian D Dynlacht
Targeted Screen for Novel Chemical Modulators of Wnt/Beta-Cat Signaling Pathway.
Breast